Percutaneous Localization: Open-label Registry of Thoracic Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-10

Study Completion Date

2023-02-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are to evaluate intraoperative percutaneous lung lesion marking assisted by electromagnetic guided percutaneous navigation and related tools.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preoperative Computed Tomography-guided Localization for Lung Nodules: Localization Needle Versus Coil

NCT05183945

Lung; Node

UNKNOWN NA

Pulmonary Nodule Localization Prospective Validation

NCT04690790

Video-assisted Thoracic Surgery Pulmonary Nodules

UNKNOWN

Semi-barbed Suture for Pulmonary Small Nodules Localization

NCT04168359

Suture Nodule, Solitary Pulmonary Video-Assisted Thoracoscopic Surgery

COMPLETED NA

Cone-beam CT Guided Microcoil Localization of Pulmonary Nodules During Video Assisted Thoracic Surgery(VATS)

NCT02496624

Lung Cancer

RECRUITING NA

Removal of Lung Nodules After Being Marked With a Microcoil

NCT00323089

Lung Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Intraoperative, Percutaneous Localization of Peripheral Pulmonary Nodules for Resection: a Prospective, Open-Label, Multi-Center Registry Study of Thoracic Surgery Outcomes (PLOTS) registry is aimed at developing a high quality set of data regarding intraoperative percutaneous localization of peripheral pulmonary nodules (PPNs), and then identifying and promulgating efficient, evidence-based best practices for this technique. The resection procedure itself is standard of care and follows the investigator's standard protocol.

Successful localization of PPNs is a challenge involving multiple factors, beginning with the subjects' health, lung function and also factors specific to the nodule including location within the lung, size, distance from the lung surface, whether solid or ground glass and proximity to a fissure. Hard to see or palpate nodules are currently localized with dye and/or hook wires or fiducials, either endoscopically or percutaneously. Successful, large, prospective studies have not been reported using modern electro-magnetic navigation (EMN)-guided percutaneous intraoperative localization, and different techniques (dye vs. fiducial vs. hook wire etc.) have not been broadly evaluated. It is for these reasons that the different localization techniques used with EMN-guided percutaneous localization will be collected for patients having a suspicious nodule and who undergo percutaneous intra-operative localization and immediate resection.

This registry aims to record the localization techniques used by thoracic surgeons and IP/surgical teams to identify PPNs using the SPiN Thoracic Navigation System™ in the hands of trained physicians. The objectives of this study will be to accomplish the primary and secondary objectives listed below, and to observe localization in a real world context of pulmonary resection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Lesion(s) Requiring Evaluation Pulmonary Metastasis Pulmonary Nodule, Solitary Peripheral Lung Lesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Localization

Electromagnetic navigation (EMN) guided percutaneous localization of suspicious lung lesion(s).

Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools.

Intervention Type PROCEDURE

Transthoracic localization of suspicious lung lesion(s) in preparation for subsequent resection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous localization of suspicious lung lesion(s) using electromagnetic navigation and tools.

Transthoracic localization of suspicious lung lesion(s) in preparation for subsequent resection.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SPiN Thoracic Navigation System™ Veran System

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject's physician and/or thoracic surgeon have deemed/has deemed that the surgical removal of the PPN is appropriate.
* A clinical decision has been made to use the SPiN Thoracic Navigation System™.
* Subject is at least 18 years of age at time of study entry.
* Subject is able to read, understand, and voluntarily sign the IRB-approved informed consent document prior to the performance of any study-specific procedures. IRB- approved translation may be used if indicated. Reasonable accommodation of visually impaired subjects will be allowed.
* Subject is able to tolerate general anesthesia.
* Subject has a target nodule between 0.4 cm and 3.2 cm in greatest dimension;
* The target nodule is in a location that is accessible for percutaneous localization in the judgement of the surgeon.

Exclusion Criteria

* Subjects with any other concomitant treatment or medical condition that, in the opinion of the clinician, would render peripheral nodule resection more hazardous than beneficial.
* Subject is pregnant.
* Pulmonary nodule is greater than 3.2 cm.
* Subjects with significant coagulopathy having INR \> 2.0 or PTT \> 2x normal.
* Subject is unable to tolerate general anesthesia.
* Obese subject, impacting percutaneous access (BMI \> 50).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No